San Jose, California — Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the SmartChip ND Real-Time PCR System, an automated, research-use-only (RUO), high-throughput qPCR solution for infectious disease research. Takara Bio USA is now accepting orders of the SmartChip ND Real-Time PCR System. The SmartChip ND […]
Integral Molecular, a leader in antibody discovery and characterization, has been awarded $2.7 million by the NIH Commercialization Readiness Pilot (CRP) Program. This funding will support FDA-qualification of Integral Molecular’s Membrane Proteome Array™ (MPA), a next-generation technology that provides critical safety data required for Investigational New Drug (IND) filings of biologic drugs. The MPA is […]
Launch of new application enables global access to highly recognized solid tumor profiling assay Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, announced the global launch of MSK-IMPACT® powered with SOPHiA DDM™ today from the Association for Molecular Pathology (AMP) Annual Meeting. This innovative solution provides […]
The oversubscribed funding round was led by existing investors Archangels with participation from Old College Capital, Scottish Enterprise and British Business Bank. New investment will allow Cytomos to drive sales of its first commercial product, Celledonia™, built on its cell-analysis technology platform AuraCyt, which is already generating significant market traction. Celledonia™ is a benchtop cell analyser […]
The TotalSeq Phenocyte solution supports robust study of cellular heterogeneity and rare cell types in complex samples at a single cell level SAN DIEGO — Scale Biosciences (Scale Bio TM ), a leader in innovative and scalable single cell analysis solutions, and Revvity’s (NYSE: RVTY) BioLegend business, a leading provider of world-class biological reagents and tools, today […]
The latest solution to enable comprehensive genomic profiling of tumors will be presented at the annual meeting of the Association of Molecular Pathology Customer-led research and presentations at the conference will deliver the latest evidence and education in tumor profiling SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that […]
Leading Genomics Information Company brings new innovation to genomics interpretation and consultation, in its mission to enhance the utility of the genome NEW YORK — Dante Genomics, a global leader in genomics and personalized medicine, announced today that it will begin integrating Generative AI features into its first product, the Dante Labs Whole Genome platform. […]
Antibodies and conjugates to illuminate your research Caption: Immunofluorescence microscopy of transgenic mouse liver constitutively expressing a GFP fusion protein using JIR Anti-GFP Antibody. West Grove, PA – Jackson ImmunoResearch, a manufacturer of secondary antibodies and immunoreagents for the life science market, announces a new addition to its range of products for scientists seeking to […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced a strategic partnership with ALZpath, Inc to accelerate breakthroughs in neurodegenerative disease research and treatment, including Alzheimer’s disease. The collaboration leverages Bio-Techne’s Ella™ fully automated, multiplexing immunoassay platform and ALZpath’s proprietary pTau217 antibody to provide the Simple Plex Human Phospho-Tau (T217) ALZpath Assay. The ALZpath pTau217 (phosphorylated Tau217) antibody is […]
Zurich, Switzerland — InSphero, the global leader in scalable and reliable 3D in vitro cell culture solutions for drug discovery, takes a leading role in the recently awarded Chips JU European UNLOOC Project to advance its technology platform and address diversity in drug efficacy and safety testing. Launched in May 2024, the Project UNLOOC – Unlocking data content of Organ-on-Chips – […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
